Literature DB >> 16556707

Failure of transdifferentiation of adult hematopoietic stem cells into neurons.

Laurent Roybon1, Zhi Ma, Fredrik Asztely, Anna Fosum, Sten Eirik W Jacobsen, Patrik Brundin, Jia-Yi Li.   

Abstract

Previous studies of bone marrow-derived stem cell transdifferentiation into neurons have not involved purified cell populations and determined their exact phenotype prior to differentiation. The present study investigates whether highly purified mouse adult hematopoietic stem cells (HSCs), characterized by lineage marker depletion and expression of the cell surface markers Sca1 and c-Kit (Lin(-) Sca1(+) c-Kit(+) [LSK]), can be stimulated to adopt a neuronal fate. When the HSC(LSK) cells were cultured in vitro in neuronal differentiation medium supplemented with retinoic acid, 50% of the cells expressed the neural progenitor marker nestin and no cells had become postmitotic. Electrophysiological recordings on neuron-like cells showed that these cells were incapable of generating action potentials. When the HSC(LSK) cells either were grown in vitro together with neural precursor cells or were transplanted into the striatum or cerebellum of wild-type mouse, they either differentiated into Iba1-immunopositive macrophage/microglia or died. In conclusion, we demonstrate that adult HSC(LSK) cells do not have the capacity to leave the hematopoietic lineage and differentiate into neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556707     DOI: 10.1634/stemcells.2005-0548

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  22 in total

Review 1.  Stemming vision loss with stem cells.

Authors:  Valentina Marchetti; Tim U Krohne; David F Friedlander; Martin Friedlander
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

2.  Evaluation of bone marrow- and brain-derived neural stem cells in therapy of central nervous system autoimmunity.

Authors:  Jingxian Yang; Yaping Yan; Bogoljub Ciric; Shuo Yu; Yangtai Guan; Hui Xu; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 3.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

4.  The level and distribution pattern of HP1β in the embryonic brain correspond to those of H3K9me1/me2 but not of H3K9me3.

Authors:  Eva Bártová; Josef Večeřa; Jana Krejčí; Soňa Legartová; Jiří Pacherník; Stanislav Kozubek
Journal:  Histochem Cell Biol       Date:  2016-01-21       Impact factor: 4.304

5.  Blood-derived small Dot cells reduce scar in wound healing.

Authors:  Wuyi Kong; Shaowei Li; Michael T Longaker; H Peter Lorenz
Journal:  Exp Cell Res       Date:  2008-02-09       Impact factor: 3.905

Review 6.  Nuclear receptor regulation of stemness and stem cell differentiation.

Authors:  Yangsik Jeong; David J Mangelsdorf
Journal:  Exp Mol Med       Date:  2009-08-31       Impact factor: 8.718

7.  Lithium enhanced cell proliferation and differentiation of mesenchymal stem cells to neural cells in rat spinal cord.

Authors:  Bao-Tie Dong; Guan-Jun Tu; Ya-Xin Han; Yi Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

8.  Progenitor cells as remote "bioreactors": neuroprotection via modulation of the systemic inflammatory response.

Authors:  Peter A Walker; Phillip A Letourneau; Supinder Bedi; Shinil K Shah; Fernando Jimenez; Charles S Cox
Journal:  World J Stem Cells       Date:  2011-02-26       Impact factor: 5.326

9.  Progenitor cell therapy for the treatment of central nervous system injury: a review of the state of current clinical trials.

Authors:  Peter A Walker; Matthew T Harting; Shinil K Shah; Mary-Clare Day; Ramy El Khoury; Sean I Savitz; James Baumgartner; Charles S Cox
Journal:  Stem Cells Int       Date:  2010-07-20       Impact factor: 5.443

10.  Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells.

Authors:  S Kuçi; Z Kuçi; S Schmid; G Seitz; I Müller; A Dufke; T Leimig; G Murti; R Jurecic; M Schumm; P Lang; G Bruchelt; P Bader; T Klingebiel; D Niethammer; R Handgretinger
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.